Merit Medical Systems, Inc.
NASDAQ:MMSIMedical - Instruments & Supplies
+$1.16 today
- Market cap
- $5.15B
- Beta
- 0.53
- P/E (TTM)
- 28.4
- EPS (TTM)
- $2.34
Volume 0.46M
Average 0.79M
MMSI Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Merit Medical Systems, Inc.NASDAQ: MMSI
Net Margin · Q3 FY2026 · quarter ended Sep 2026
Net margin widens to 10.2%
Net margin was 10.2% in Q3 FY2026, up 2.9 pp from a year earlier. On a trailing-twelve-month basis it was 9.9%, up 1.9 pp year over year. Over 3 fiscal years it widened by 2.0 pp.
Context
- Net margin widened in 2 of the last 3 fiscal years.
What to watch
Whether net margin reaches the consensus estimate from 9 analysts of 16.0% for the fiscal year ending Dec 2026, up from 8.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 10.2%+0.9 pp QoQ
- Last fiscal yearDec 2025
- 8.5%-0.4 pp YoY
- LTMSep 2026
- 9.9%+1.9 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +2.9 pp | +6.2 pp | +3.2 pp |
| 1 year | -0.4 pp | +7.5 pp | +7.9 pp |
| 3 years | +2.0 pp | +8.5 pp | +6.5 pp |
| 5 years | +7.7 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 8.5%
- Year-over-year change
- -0.4pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.5% | -0.4pp |
| FY2024 | 2024-12-31 | 8.9% | +1.4pp |
| FY2023 | 2023-12-31 | 7.5% | +1.0pp |
| FY2022 | 2022-12-31 | 6.5% | +2.0pp |
| FY2021 | 2021-12-31 | 4.5% | — |
Net Margin vs competitors
How MMSI compares with its peers on the latest reported figures
- MMSI's LTM Sep 2026 net margin of 9.9% is the 4th highest of the 10 companies compared; the peer median is 4.0%.
- Its year-over-year change of +1.9 pp is the 7th highest of 10, against a peer median of +3.9 pp.
- Over three fiscal years its change of +2.0 pp compares with a peer median of +3.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 24.3% | +4.4 pp | +10.4 pp | |
| LTM Jun 2026 | 17.5% | +3.9 pp | +8.9 pp | |
| LTM Jun 2026 | 17.3% | +12.7 pp | +2.2 pp | |
| LTM Sep 2026 | 9.9% | +1.9 pp | +2.0 pp | |
| LTM Sep 2026 | 5.7% | -2.0 pp | -1.8 pp | |
| LTM Mar 2026 | 4.0% | -5.0 pp | +11.1 pp | |
| LTM Jun 2026 | 1.9% | +9.1 pp | +11.9 pp | |
| LTM Jun 2026 | 1.4% | +3.0 pp | +3.3 pp | |
| LTM Feb 2026 | -10.0% | +4.6 pp | -3.2 pp | |
| LTM Jun 2026 | -39.6% | -45.9 pp | -58.5 pp | |
| Peer median (excluding MMSI) | 4.0% | +3.9 pp | +3.3 pp | |
Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.07B | 1.15B | 1.26B | 1.36B | 1.51B |
| Cost of Revenue | 589.42M | 631.88M | 673.49M | 713.18M | 777.79M |
| Gross Profit | 485.33M | 519.1M | 583.87M | 643.33M | 736.94M |
| Gross Margin | 45.2% | 45.1% | 46.4% | 47.4% | 48.7% |
| Research & Development | 71.25M | 75.51M | 82.73M | 83.81M | 97.35M |
| Selling, General & Admin | 335.69M | 342.53M | 373.68M | 376.73M | 455.21M |
| Operating Expenses | 424.42M | 431.54M | 458.73M | 487.64M | 552.57M |
| Depreciation & Amortization | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M |
| EBITDA | 154.96M | 181.17M | 228.89M | 273.97M | 332.05M |
| EBITDA Margin | 14.4% | 15.7% | 18.2% | 20.2% | 21.9% |
| Operating Income | 60.92M | 87.56M | 123.94M | 155.69M | 184.38M |
| Operating Margin | 5.7% | 7.6% | 9.9% | 11.5% | 12.2% |
| Interest Income | 769K | 439K | 2.46M | 26.23M | 15.07M |
| Interest Expense | 5.26M | 6.34M | 15.51M | 31.22M | 26.46M |
| Other Income / Expenses | (7M) | (4.93M) | (11.86M) | (5.7M) | (13.44M) |
| Income Before Tax | 53.92M | 82.63M | 112.09M | 149.99M | 170.94M |
| Pre-Tax Margin | 5.0% | 7.2% | 8.9% | 11.1% | 11.3% |
| Income Tax Expense | 5.46M | 8.11M | 17.68M | 29.64M | 42.45M |
| Net Income | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M |
| Net Margin | 4.5% | 6.5% | 7.5% | 8.9% | 8.5% |
| EPS (Basic) | 0.86 | 1.31 | 1.64 | 2.07 | 2.17 |
| EPS (Diluted) | 0.84 | 1.29 | 1.62 | 2.03 | 2.13 |
| Weighted Avg Shares | 56.15M | 56.81M | 57.59M | 58.22M | 59.16M |
| Weighted Avg Shares (Diluted) | 57.36M | 57.67M | 58.36M | 59.37M | 60.46M |
Merit Medical Systems, Inc.
NASDAQ:MMSI
Intrinsic Alpha fair value
Locked
Current Price
$85.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.